Bristol-Myers Squibb and a former subsidiary have agreed to pay $515 million to 43 states and the federal government to settle accusations stemming from the marketing of antipsychotic drugs. Investigators alleged that the drug makers wrongly marketed antipsychotic medicines to children and dementia patients, made illegal payments to doctors and overpriced drugs.  AP, Boston Globe  07/20/2008
Read article: http://www.boston.com/news/local/new_hampshire/articles/2008/07/20/nh_reps_want_to_get_tough_with_drug_manufacturers/

President Shelene Giles provided an update on the work of the Executive Board of the American Association of Nurse Life Care Planners.  The goals of the association were broken down and shared with the membership.
Some ideas of short term goals:
Increase membership & CNLCP certificants
Establish quarterly newsletter
Member Survey & Non-renewal Member Survey
Develop Power Point Presentation describing NLCP for marketing/education
Developing mentor relationship among new & seasoned members
Complete/print Core Curriculum
Offer CEUs through journal
Revising/reprinting association marketing materials – make available for members
 
Some ideas of long term goal
ABNS accreditation
CEU options through association
Online Bookstore
Increase …

Nurse Builders (Louise Jakubik, DNSc, CRNP, APRN-BC) is holding the first Nursing Certification Review Symposium November 5 and 6, 2008 in Daytona Beach, Florida where they will bring together five certification review courses of which one is in Legal Nurse Consulting.The Legal Nurse Consultant (LNCC) Certification Review Course will be taught by Patricia Iyer, MSN, RN, LNCC and Rose Clifford, RN, LNCC.
 

 
 
To learn more about the event check out Nurse Builders at http://www.nursebuilders.net/nursesymposium.htm 

A California jury on Thursday declined to award damages to a family that claimed Children’s Motrin left their daughter legally blind. Jurors found that the plaintiffs had not sufficiently proved that Children’s Motrin was to blame for the girl’s injuries. The family had contended that Johnson & Johnson failed to adequately warn that the medicine’s active ingredient, ibuprofen, could cause a rare allergic reaction known as Stevens-Johnson Syndrome.  
Reuters, Reuters  07/17/2008
Read article: Reuters